@article{3183949,
    title = "Clinical outcomes according to PD-L1 status and age in the prospective
international SAUL study of atezolizumab (atezo) for locally advanced or
metastatic urothelial carcinoma (UC) or non-UC of the urinary tract.",
    author = "Sternberg, Cora N. and Merseburger, Axel Stuart and Choy, Ernest and and Castellano, Daniel E. and Lopez-Rios, Fernando and James, Nicholas and and Banna, Giuseppe Luigi and De Giorgi, Ugo and Masini, Cristina and and Bamias, Aristotelis and del Muro, Xavier Garcia and Powles, Thomas and and Duran, Ignacio and Gedye, Craig and Gamulin, Marija and Zengerling, and Friedemann and Geczi, Lajos and de Ducla, Sabine and Fear, Simon and and Loriot, Yohann",
    journal = "World Journal of Clinical Oncology",
    year = "2019",
    volume = "37",
    number = "15, S",
    publisher = "AMER SOC CLINICAL ONCOLOGY 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA",
    doi = "10.1200/JCO.2019.37.15_suppl.4519"
}